Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Microtubule-targeting agents and their impact on cancer treatment
Vladimı́r Čermák, Vojtěch Dostál, Michael Jelínek, et al.
European Journal of Cell Biology (2020) Vol. 99, Iss. 4, pp. 151075-151075
Closed Access | Times Cited: 189

Showing 1-25 of 189 citing articles:

Therapeutic strategies to overcome taxane resistance in cancer
Tuyelee Das, Uttpal Anand, Swaroop Kumar Pandey, et al.
Drug Resistance Updates (2021) Vol. 55, pp. 100754-100754
Closed Access | Times Cited: 154
BRD4-directed super-enhancer organization of transcription repression programs links to chemotherapeutic efficacy in breast cancer
Beibei Liu, Xinhua Liu, Lulu Han, et al.
Proceedings of the National Academy of Sciences (2022) Vol. 119, Iss. 6
Open Access | Times Cited: 73
STIMULI-RESPONSIVE SUPRAMOLECULAR HYDROGELS FOR PACLITAXEL DELIVERY: PROGRESS AND PROSPECTS
Mohammad Qutub, Amol Tatode, Jayshree Taksande, et al.
Aspects of Molecular Medicine (2025) Vol. 5, pp. 100062-100062
Open Access | Times Cited: 5
Discovery of Novel Benzimidazole and Indazole Analogues as Tubulin Polymerization Inhibitors with Potent Anticancer Activities
Yichang Ren, Yuxi Wang, Gang Li, et al.
Journal of Medicinal Chemistry (2021) Vol. 64, Iss. 8, pp. 4498-4515
Closed Access | Times Cited: 81
Gatorbulin-1, a distinct cyclodepsipeptide chemotype, targets a seventh tubulin pharmacological site
Susan Matthew, Qi-Yin Chen, Ranjala Ratnayake, et al.
Proceedings of the National Academy of Sciences (2021) Vol. 118, Iss. 9
Open Access | Times Cited: 67
Interplay between Cell Death and Cell Proliferation Reveals New Strategies for Cancer Therapy
Luke V. Loftus, Sarah R. Amend, Kenneth J. Pienta
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 9, pp. 4723-4723
Open Access | Times Cited: 65
A Systematic Review of the Biological Effects of Cordycepin
Masar Radhi, Sadaf Ashraf, Steven Lawrence, et al.
Molecules (2021) Vol. 26, Iss. 19, pp. 5886-5886
Open Access | Times Cited: 61
Medicinal Chemistry of Indane and Its Analogues: A Mini Review
Parteek Prasher, Mousmee Sharma
ChemistrySelect (2021) Vol. 6, Iss. 11, pp. 2658-2677
Closed Access | Times Cited: 59
PI3K/AKT Signaling Tips the Balance of Cytoskeletal Forces for Cancer Progression
Shuo Deng, Hin Chong Leong, Arpita Datta, et al.
Cancers (2022) Vol. 14, Iss. 7, pp. 1652-1652
Open Access | Times Cited: 54
Updates in IDH-Wildtype Glioblastoma
Jawad Melhem, Jay Detsky, Mary Jane Lim-Fat, et al.
Neurotherapeutics (2022) Vol. 19, Iss. 6, pp. 1705-1723
Open Access | Times Cited: 47
Destruction of tumor vasculature by vascular disrupting agents in overcoming the limitation of EPR effect
Zhilin Liu, Yu Zhang, Na Shen, et al.
Advanced Drug Delivery Reviews (2022) Vol. 183, pp. 114138-114138
Closed Access | Times Cited: 42
Microtubule Assists Actomyosin to Regulate Cell Nuclear Mechanics and Chromatin Accessibility
Jiwen Geng, Zhefeng Kang, Qian Sun, et al.
Research (2023) Vol. 6
Open Access | Times Cited: 37
Engine shutdown: migrastatic strategies and prevention of metastases
Martina Raudenská, Kateřina Petrláková, Tamara Juriňáková, et al.
Trends in cancer (2023) Vol. 9, Iss. 4, pp. 293-308
Open Access | Times Cited: 34
Microtubule‐targeting agents for cancer treatment: Seven binding sites and three strategies
Xingyu Wang, Benoı̂t Gigant, Xi Zheng, et al.
MedComm – Oncology (2023) Vol. 2, Iss. 3
Open Access | Times Cited: 30
Weakened APC/C activity at mitotic exit drives cancer vulnerability to KIF18A inhibition
Colin R. Gliech, Zhong Y. Yeow, Daniel Tapias-Gomez, et al.
The EMBO Journal (2024) Vol. 43, Iss. 5, pp. 666-694
Open Access | Times Cited: 15
Positioning centrioles and centrosomes
Matthew R. Hannaford, Nasser M. Rusan
The Journal of Cell Biology (2024) Vol. 223, Iss. 4
Open Access | Times Cited: 13
Molecular and Cellular Involvement in CIPN
Housem Kacem, Annamaria Cimini, Michele d’Angelo, et al.
Biomedicines (2024) Vol. 12, Iss. 4, pp. 751-751
Open Access | Times Cited: 8
The New Microtubule-Targeting Agent SIX2G Induces Immunogenic Cell Death in Multiple Myeloma
Katia Grillone, Caterina Riillo, Roberta Rocca, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 18, pp. 10222-10222
Open Access | Times Cited: 31
Copper-Plumbagin Complex Produces Potent Anticancer Effects by Depolymerizing Microtubules and Inducing Reactive Oxygen Species and DNA Damage
Sandipan Mukherjee, Avishkar V. Sawant, Shweta Shyam Prassanawar, et al.
ACS Omega (2023) Vol. 8, Iss. 3, pp. 3221-3235
Open Access | Times Cited: 20
Combination Therapy as a Promising Way to Fight Oral Cancer
João P. N. Silva, Bárbara Pinto, Luı́s Monteiro, et al.
Pharmaceutics (2023) Vol. 15, Iss. 6, pp. 1653-1653
Open Access | Times Cited: 20
Pt(iv) anticancer prodrugs bearing an oxaliplatin scaffold: what do we know about their bioactivity?
Alvaro Lopez-Sanchez, Hélène Bertrand
Inorganic Chemistry Frontiers (2024) Vol. 11, Iss. 6, pp. 1639-1667
Closed Access | Times Cited: 7
From Crypts to Cancer: A Holistic Perspective on Colorectal Carcinogenesis and Therapeutic Strategies
Ehsan Gharib, Gilles A. Robichaud
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 17, pp. 9463-9463
Open Access | Times Cited: 7
TUBB, a robust biomarker with satisfying abilities in diagnosis, prognosis, and immune regulation via a comprehensive pan-cancer analysis
Zaifu Zhu, Wei Zhang, Shaohu Huo, et al.
Frontiers in Molecular Biosciences (2024) Vol. 11
Open Access | Times Cited: 6
Tirbanibulin for Actinic Keratosis: Insights into the Mechanism of Action
Todd Schlesinger, Eggert Stockfleth, Ayman Grada, et al.
Clinical Cosmetic and Investigational Dermatology (2022) Vol. Volume 15, pp. 2495-2506
Open Access | Times Cited: 27
Computational Approaches to the Rational Design of Tubulin-Targeting Agents
Helena Pérez‐Peña, Anne‐Catherine Abel, M. D. Shevelev, et al.
Biomolecules (2023) Vol. 13, Iss. 2, pp. 285-285
Open Access | Times Cited: 14
Page 1 - Next Page

Scroll to top